ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,495.20
0.56%
S&P ASX All Technology
4,017.00
1.28%
Brent Oil
73.585
2.36%
US Dollar vs AUD
1.54201
-0.16%
Bitcoin
95,704.60
-0.16%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Italy
  5. BIT

  6. Biogen Inc (1BIIB) Share Price

Biogen Inc

Biogen Inc (1BIIB)

BIT
155.15
3.15
(2.07%)
Closed 04 December 3:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
155.15
Bid
153.00
Offer
155.15
Volume
46
154.00 Day's Range 155.25
146.95 52 Week Range 244.60
Market Cap
22.608B
Previous Close
152.00
Open
155.25
Last Trade
16
@
155.15
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
45
Shares Outstanding
145,719,340
Dividend Yield
-
PE Ratio
20.43
Earnings Per Share (EPS)
7.97
Revenue
9.84B
Net Profit
1.16B

About Biogen Inc

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.biogen.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Biogen Inc is listed in the Biological Pds,ex Diagnstics sector of the Italian Stock Exchange with ticker 1BIIB. The last closing price for Biogen was 152.00 €. Over the last year, Biogen shares have traded in a share price range of 146.95 € to 244.60 €.

Biogen currently has 145,719,340 shares in issue. The market capitalisation of Biogen is 22.15 € billion. Biogen has a price to earnings ratio (PE ratio) of 20.43.

Ask ADVFN Intelligence (AI)

1BIIB Latest News

More News

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity Dapirolizumab pegol (DZP) met its...

19 November 2024
UK Regulatory

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease TOKYO and CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd...

15 November 2024
UK Regulatory

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference -New testing method highlights link...

31 October 2024
UK Regulatory

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases The collaboration aims to...

30 October 2024
UK Regulatory

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer CAMBRIDGE, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has appointed Daniel Quirk, M.D., M.P.H., M.B.A. as...

29 October 2024
UK Regulatory

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025 Robin Kramer, Chief Accounting Officer, to Succeed HimCAMBRIDGE, Mass., Oct. 28, 2024 (GLOBE...

28 October 2024
UK Regulatory

Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024

Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024 The detailed study results confirmed interim...

27 October 2024
UK Regulatory

Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference

Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference CAMBRIDGE, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB...

24 October 2024
UK Regulatory

Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024

Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024 Late breaker oral presentation to feature final results of the Phase 2 IGNAZ study...

22 October 2024
UK Regulatory

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients Designation is based on data from the...

09 October 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
15.253.50233488993149.9155.25149.926151.69873418DE
4-13.2-7.84080784081168.35168.35146.9533157.13221709DE
12-24.7-13.7336669447179.85182146.9545167.77678959DE
26-51.85-25.0483091787207220.7146.9539180.6355321DE
52-60.45-28.0380333952215.6244.6146.9533192.38794181DE
156-60.45-28.0380333952215.6244.6146.9533192.38794181DE
260-60.45-28.0380333952215.6244.6146.9533192.38794181DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TALEAATalea Group AA
0.0248 €
(44.19%)
1.6M
WGIS26Gismondi 1754 SpA
0.1042 €
(29.76%)
401
WOSA25OSAI Automation System SpA
0.3289 €
(21.86%)
250
DOVAADovalue AA
1.60 €
(19.23%)
603.85k
FDAFidia
0.09 €
(14.80%)
5.37M
WISC24Integrated System Credit Consulting Fintech Spa
0.0002 €
(-93.33%)
56k
EPHEPH SpA
0.53 €
(-41.76%)
8.36k
WTFINTrevi Finanziaria Industriale Spa
0.9925 €
(-22.46%)
80
OSAOSAI Automation System SpA
0.66 €
(-14.29%)
91.24k
NTWNetweek SpA
0.011 €
(-14.06%)
675.33k
TITTelecom Italia SpA
0.2239 €
(0.13%)
119.9M
ISPIntesa Sanpaolo Spa
3.6925 €
(1.67%)
55.37M
SPMSaipem Spa
2.506 €
(2.92%)
49.46M
ENELEnel Spa
6.925 €
(1.38%)
29.79M
STLAMStellantis NV
11.968 €
(1.89%)
20.86M

Discussion

View Full Feed
Biowatch Biowatch 3 minutes ago
Dew is stating his opinion, not giving fiduciary advice. Plenty of people have disagreed with Dew on numerous occasions.

Dew can be wrong, as all of us can, especially in biotech. I admit, most biotechs go up after FDA approval of their main product, but RVNC has been the exception,
RVNC
Biowatch Biowatch 3 minutes ago
Dew is stating his opinion, not giving fiduciary advice. Plenty of people have disagreed with Dew on numerous occasions.

Dew can be wrong, as all of us can, especially in biotech. I admit, most biotechs go up after FDA approval of their main product, but RVNC has been the exception,
RVNC
Poo28 Poo28 3 minutes ago
Total BS and wrong every time. Shareholders know.

The Company had developed new AI products which were described at the OTCM presentation and in the text of the 10-K and in the Update. Revenues to the consultancy are far higher than the previous commoditized services. DBMM will prese
DBMM OTCM
fink fink 4 minutes ago
Hell of a thick floor @ .0034

Who wants out? That's your ticket.
IGPK
mr34 mr34 4 minutes ago
When do you expect Revenue ? The narrative is 2026 now
SDRC
CHILLWILL1704 CHILLWILL1704 4 minutes ago
death by 1000 cuts---slow torture--thanks Mr L for the great Xmas gift to your faithful backers.
MVNT
konshe konshe 4 minutes ago
lets hit 7, close on 8
ASII
mike papa mike papa 4 minutes ago
A bit strange that we have
all this good news and are a $0.0269 stock ?
XCRT
Tstorm Tstorm 4 minutes ago
Nice job what these scumbags did to this shell, I'd hang em if i could........
LBRG
BullNBear52 BullNBear52 5 minutes ago
That is their Safe Harbor statement. I'm sure BDO has similar statements when they conduct an audit.
i_dont_know i_dont_know 5 minutes ago
Well, what a shame it’s come to this.

I get it. Really, I do. But let’s be honest—this market has completely lost faith in BLPG. Maybe there’s something going on behind the scenes that we’re not privy to, but from the outside, it’s not looking good.

Driving cash back an
BLPG
toohot toohot 5 minutes ago
I bought a couple million more of BIEL. I’m just a couple ticks away from total profitability. Dollar cost averaging is really paying off! Watch what happens when there’s 1,000,000,000+ trading day.
BOOM!!!



BUY $BIEL$
BIEL
BeachBum BeachBum 5 minutes ago
50 mil comes off the ask. PSRU
PSRU
Krombacher Krombacher 5 minutes ago
Stop trying to put words in my mouth.

I'm not walking back anything, in fact I'm doubling down.

You have no idea what's going on.

But, we are going to take all the short seller's money.

ALL OF IT.

You had your choice and
ERHE
sweet crude sweet crude 5 minutes ago
$ELEK .02 data centers + crypto

https://x.com/techwizardtom/status/1863949129916797139
ELEK
CommodityCoverage CommodityCoverage 5 minutes ago
With the injection of $10M in cash yesterday, increasing the company's total to over $16M, American Pacific Mining (USGD.c USGDF) will be allocating the "lions share" toward its Madison Copper-Gold Project in Montana where drilling recently revealed exceptional grades of up to 80.6 g/t gold, 5.2% co
USGDF
stockprofitter stockprofitter 5 minutes ago
Thanks I have the same question

Funds settlement manip prolly

Stupid post should delete it
FNMA
chumfm chumfm 6 minutes ago
Went up 240% on little to no news.The next news drop will send this to 10 plus cents.They are now readying the next announcement to send this.Good luck and good trading.
BTZI
chrislal chrislal 6 minutes ago
Agreed. There are lots of people who were scammed including myself. I lost over $60k in this one.
LFAP
oldstocks oldstocks 6 minutes ago
Yes TJG just explained it best
O T C N
Nobody wants their shares
AFFU
glenn1919 glenn1919 6 minutes ago
CYCC......CTXR......KDLY......KITT.................https://stockcharts.com/h-sc/ui?s=KITT&p=D&yr=0&mn=2&dy=12&id=p84071410134
CTXR CYCC KDLY
tedpeele tedpeele 6 minutes ago
JUST THE FACTS: INTENTIONAL CARROT DANGLING

ALL of the below facts = intentional carrot dangling except for the dummies, phonies, and paid promotors here

*10 years in a row of 10k saying commercial acceptance expected that year

*2
ASM
ducci1 ducci1 6 minutes ago
Ridin 603C .46! From Triangle Base ?
SPY
nowwhat2 nowwhat2 6 minutes ago
And if I may ask......Just how are you navigating or arriving at that link.......
https://ih.advfn.com/crypto/Bitcoin-BTC/chart/real-time
Because for me it's quite a convoluted process......


https://investorshub.advfn.com/uimage/uploads/2024/12/3/gyonnoverview.jp
sweet crude sweet crude 6 minutes ago
$ELEK .02 data centers + crypto

https://x.com/techwizardtom/status/1863949129916797139
ELEK

Your Recent History

BIT
1BIIB
Biogen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved